Follow
Kathrine Røe Redalen
Title
Cited by
Cited by
Year
Quantitative imaging for radiotherapy purposes
OJ Gurney-Champion, F Mahmood, M van Schie, R Julian, B George, ...
Radiotherapy and Oncology 146, 66-75, 2020
762020
An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer
T Bjørnetrø, KR Redalen, S Meltzer, NS Thusyanthan, R Samiappan, ...
Journal of extracellular vesicles 8 (1), 1567219, 2019
752019
Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1 H …
T Seierstad, K Røe, B Sitter, J Halgunset, K Flatmark, AH Ree, DR Olsen, ...
Molecular Cancer 7, 1-13, 2008
592008
Circulating exosomal miR-141-3p and miR-375 in metastatic progression of rectal cancer
S Meltzer, T Bjørnetrø, LG Lyckander, K Flatmark, S Dueland, ...
Translational oncology 12 (8), 1038-1044, 2019
502019
Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer
HB Ragnum, K Røe, R Holm, L Vlatkovic, JM Nesland, EK Aarnes, ...
International Journal of Radiation Oncology* Biology* Physics 87 (4), 753-760, 2013
502013
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
SJ Bains, H Abrahamsson, K Flatmark, S Dueland, KH Hole, T Seierstad, ...
Cancer Immunology, Immunotherapy 69, 355-364, 2020
472020
Hypoxia imaging and theranostic potential of [64Cu][Cu (ATSM)] and ionic Cu (II) salts: a review of current evidence and discussion of the retention mechanisms
T Liu, M Karlsen, AM Karlberg, KR Redalen
EJNMMI research 10 (1), 1-14, 2020
452020
Personalized radiotherapy: concepts, biomarkers and trial design
AH Ree, KR Redalen
The British journal of radiology 88 (1051), 20150009, 2015
452015
Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice
T Seierstad, S Folkvord, K Røe, K Flatmark, A Skretting, DR Olsen
Neoplasia 9 (5), 392-400, 2007
412007
Learning radiation oncology in Europe: results of the ESTRO multidisciplinary survey
JE Bibault, P Franco, GR Borst, W Van Elmpt, D Thorwhart, MP Schmid, ...
Clinical and translational radiation oncology 9, 61-67, 2018
402018
Professional quality of life and burnout amongst radiation oncologists: the impact of alexithymia and empathy
P Franco, V Tesio, J Bertholet, A Gasnier, EG Del Portillo, M Spalek, ...
Radiotherapy and Oncology 147, 162-168, 2020
392020
Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study
K Røe, M Kakar, T Seierstad, AH Ree, DR Olsen
Radiation oncology 6 (1), 1-9, 2011
382011
Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF (V600E) and BRAF wild-type metastatic malignant melanoma
A Tahiri, K Røe, AH Ree, R de Wijn, K Risberg, C Busch, PE Lønning, ...
PLoS One 8 (8), e72692, 2013
372013
Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
S Folkvord, K Flatmark, T Seierstad, K Røe, H Rasmussen, AH Ree
Radiotherapy and Oncology 86 (3), 428-434, 2008
372008
Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival
KM Bakke, KH Hole, S Dueland, KK Grøholt, K Flatmark, AH Ree, ...
Acta Oncologica 56 (6), 813-818, 2017
362017
Superparamagnetic magnetite nanoparticles for cancer theranostics
A Kleinauskas, JK Kim, GH Choi, HT Kim, K Røe, P Juzenas
Reviews in Nanoscience and Nanotechnology 1 (4), 271-283, 2012
362012
Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal …
T Seierstad, K Røe, DR Olsen
Radiotherapy and Oncology 85 (2), 187-194, 2007
362007
Preclinical dynamic 18F-FDG PET – tumor characterization and radiotherapy response assessment by kinetic compartment analysis
K Røe, TB Aleksandersen, A Kristian, LB Nilsen, T Seierstad, H Qu, ...
Acta oncologica 49 (7), 914-921, 2010
352010
Professional quality of life and burnout among medical physicists working in radiation oncology: The role of alexithymia and empathy
M Di Tella, V Tesio, J Bertholet, A Gasnier, EG Del Portillo, M Spalek, ...
Physics and Imaging in Radiation Oncology 15, 38-43, 2020
342020
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
E Hagtvet, K Røe, DR Olsen
Radiation Oncology 6, 1-10, 2011
342011
The system can't perform the operation now. Try again later.
Articles 1–20